The New York Times (7/31, Shakin) reports that “a major study of the health of transgender and gender nonconforming young people is set to begin later this year in Britain.” Researchers from King’s College London “plan to track the mental and physical well-being of up to 3,000 children and teenagers who have a gender identity that differs from their sex at birth, and who have sought treatment from the country’s National Health Service. They will carry out annual surveys that look at their quality of life, body image and gender identity.” The study, funded by the NHS and the UK government’s clinical research agency, is “part of a wider 10.7 million pound, or about $14 million, initiative from King’s College that aims to find out how Britain’s health service can best support trans and gender nonconforming children and young people.”

Related Links:

— The New York Times (requires login and subscription)

Psychiatric News (7/31) reports a study found that “nearly half of individuals who develop catatonia – a neuropsychiatric syndrome marked by abnormal speech and movements – will experience a relapse within a few years.” Considering this, “providing antipsychotics at discharge can reduce relapse risk.” The researchers “examined medical records of 303 patients who were treated for catatonia at a neuropsychiatric center in India between January 2014 and December 2017 and came back for at least one follow-up visit by December 2020.” They found that “48.8% of the patients experienced catatonia relapse, with most events occurring within the first two years after the initial episode.” They observed that “patients who received an antipsychotic prescription at discharge had a 41% reduced risk of relapse compared with those who did not; this reduced risk was present in patients with or without a prior history of catatonia.” The study was published in JAMA Psychiatry.

Related Links:

— “Antipsychotics May Reduce Risk of Catatonia Relapse, Psychiatric News, July 31, 2025

HealthDay (7/29, Solomon) reports a study found that “people with any type of substance use disorder (SUD) face a higher risk for having an unplanned, 30-day hospital readmission compared with those without SUD.” Researchers observed that “patients with any SUD and patients specifically with opioid use disorder were more likely to have a 30-day unplanned readmission versus patients without SUDs. After adjusting for covariates, only patients with SUDs discharged to home or self-care had a higher risk for unplanned readmission. Among patients who eloped or who were discharged to a home health service or an inpatient facility, there was no association between SUD and 30-day unplanned readmission.” The study was published in Addiction.

Related Links:

— “Substance Use Disorder Linked to Higher Risk for Unplanned Readmissions,”
Lori Solomon, HealthDay , July 29, 2025

Stateline (7/29, Hassanein) says that a new report found that “only a dozen states have laws establishing suicide prevention offices or coordinators, and just 11 have task forces or committees dedicated to suicide prevention efforts.” The report, conducted by the Association of State and Territorial Health Officials with support from the CDC, “comes amid sweeping cuts at federal agencies that offer mental health support,” such as the Substance Abuse and Mental Health Services Administration (SAMHSA). It notes that “about 60% of states – 29 states and Washington, D.C. – have laws that establish some form of fatality review committees that specifically include suicide deaths in reviews. Areas of focus varied among the states. Some had statewide teams and others were on the local level, according to the report.”

Related Links:

— “State suicide prevention efforts are lacking amid federal cuts,” Nada Hassanein, Stateline, July 29, 2025

HealthDay (7/29, Mundell) reports a meta-analysis found “that, overall, it takes an average of three-and-a-half years after symptoms first appear for a patient to be properly diagnosed with dementia. That lag stretched to just over four years when the person was younger and experiencing early-onset dementia, the researchers said.” They noted that “younger age, as well having a form of illness known as frontotemporal dementia, were each linked to a longer time to diagnosis.” A study included in the analysis “also found that Black patients faced longer wait times to a dementia diagnosis.” The analysis was published in the International Journal of Geriatric Psychiatry.

Related Links:

— “Dementia Diagnosis Typically Comes 3.5 Years After Symptoms,”Ernie Mundell , HealthDay , July 29, 2025